CHAPEL HILL, N.C. - Federico Innocenti, MD, PhD, has been appointed associate professor of pharmacy in the UNC Eshelman School of Pharmacy. He will serve as associate director of the UNC Institute for Pharmacogenomics and Individualized Therapy and a member of UNC Lineberger Comprehensive Cancer Center.
CHAPEL HILL, N.C. - A Triangle-based UNC spinoff company at the forefront of efforts to use nanotechnology to tackle diseases has received a $10 million investment from the Bill & Melinda Gates Foundation.
James P. Evans, MD, PhD is lead author of a commentary about the potential of genomic medicine.
Weili Lin, PhD, has been appointed Director of the UNC Biomedical Research Imaging Center (BRIC).
UNC Lineberger member Kurt Ribisl, PhD, was part of the study's research team.
Sixty physicians at the University of North Carolina Hospitals are listed in the latest version of “America’s Top Doctors,” a compilation that is published annually by Castle Connolly Medical Ltd. Of those, 32 are members of UNC Lineberger Comprehensive Cancer Center or involved in UNC Cancer Care’s multidisciplinary programs.